B3gnt2 - UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Gene
Also Known as B3gnt1
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 305571
Summary
Predicted to enable N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity. Predicted to be involved in poly-N-acetyllactosamine biosynthetic process. Predicted to act upstream of or within several processes, including axon guidance; cellular response to leukemia inhibitory factor; and sensory perception of smell. Predicted to be integral component of membrane. Predicted to be active in Golgi membrane. Orthologous to human B3GNT2 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2). [provided by Alliance of Genome Resources, Apr 2022]
B3gnt2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001107240.1 | NP_001100710.1 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-149777 | B3GNT2-IN-1 | Inhibitor | 99.56% | Unkown |
| HY-RS01310 | B3GNT2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19501 | B3gnt2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25995 | B3gnt2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service